Video

The Role of Transplant in the Treatment of Patients With MF

Author(s):

Jamile Shammo, MDNaveen Pemmaraju, MD

Dr Abdulraheem Yacoub explains allogeneic hematopoietic cell transplantation in myelofibrosis, the only known curative treatment modality.

Related Videos
Video 14 - "Key Takeaways in HER2-Mutated NSCLC"
Video 13 - "Treatment Considerations in HER2-Mutated NSCLC"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Video 18 - "Reflecting on Differentiated Thyroid Cancer: Final Insights"
Video 17 - "Phase 2 ATLEP Trial Results"
Naseema Gangat, MBBS
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
A panel of 5 experts on lung cancer
Related Content
Jeremy Allred, MD
May 30th 2024

Recent Data Shed Further Light on the MDS Treatment Paradigm as the SOC Evolves

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Ashwin Kishtagari, MD, Vanderbilt University Medical Center
May 21st 2024

Navigating the Growing Landscape of JAK Inhibitors in Myelofibrosis

Courtney D. DiNardo, MD, MSCE
November 20th 2023

FDA Approval Insights: Ivosidenib in R/R IDH1+ Myelodysplastic Syndrome

Ghaith Abu-Zeinah, MD, Weill Cornell
May 8th 2024

Pooled Analysis Shows Cytoreduction to Be Safe, Tolerable in Younger Patients With PV

Benjamin Tomlinson, MD, program director, Hematology and Oncology, University Hospitals, Cleveland Medical Center; assistant professor, Case Western Reserve University School of Medicine
April 30th 2024

Expansion of Luspatercept Indication Underscores Evolving Treatment Landscape for Low-Risk MDS